Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · Real-Time Price · USD

35.10

-4.32 (-10.96%)

At close: May 12, 2025, 4:00 PM

33.90

-1.20 (-3.42%)

After-hours: May 12, 2025, 6:54 PM EDT

Monopar Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-15.59	-8.4	-10.52	-9.1	-6.3	Upgrade
Stock-Based Compensation	1.14	1.9	1.64	1.47	1.32	Upgrade
Other Operating Activities	4.55	-	-	-	-0.12	Upgrade
Change in Accounts Payable	0.51	-1.33	1.48	0.4	0.45	Upgrade
Change in Other Net Operating Assets	2.98	-0.02	0.17	-0.09	-0	Upgrade
Operating Cash Flow	-6.4	-7.86	-7.23	-7.32	-4.66	Upgrade
Investment in Securities	-14.34	4.93	-4.92	-	-	Upgrade
Investing Cash Flow	-14.34	4.93	-4.92	-	-	Upgrade
Long-Term Debt Issued	-	-	-	-	0.12	Upgrade
Net Debt Issued (Repaid)	-	-	-	-	0.12	Upgrade
Issuance of Common Stock	59.4	2.07	0.11	11.28	8.43	Upgrade
Repurchase of Common Stock	-0.1	-0.05	-0.08	-0.06	-	Upgrade
Other Financing Activities	-	-	-	-0.34	-0.37	Upgrade
Financing Cash Flow	59.29	2.03	0.03	10.88	8.18	Upgrade
Foreign Exchange Rate Adjustments	0	-0.02	-0	0	0	Upgrade
Net Cash Flow	38.55	-0.92	-12.12	3.57	3.52	Upgrade
Cash Income Tax Paid	-	-	-	-	-0.01	Upgrade
Levered Free Cash Flow	-5.48	-5.01	-3.22	-3.99	-2.34	Upgrade
Unlevered Free Cash Flow	-5.48	-5.01	-3.22	-3.99	-2.34	Upgrade
Change in Net Working Capital	-3.48	1.39	-1.72	-0.25	-0.41	Upgrade

Updated Nov 8, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q